|
|
Volumn 2, Issue 1, 2000, Pages 101-110
|
|
Safety of drugs commonly used to treat hypertension, dyslipidemia, and type 2 diabetes (The Metabolic Syndrome): Part 1
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIHYPERTENSIVE AGENT;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CALCIUM ANTAGONIST;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
GLUCOSE;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
INSULIN;
LOW DENSITY LIPOPROTEIN CHOLESTEROL;
STATIN;
SULFONYLUREA DERIVATIVE;
TROGLITAZONE;
ANGIONEUROTIC EDEMA;
ANTIHYPERTENSIVE ACTIVITY;
CANCER;
DRUG SAFETY;
DYSLIPIDEMIA;
GLUCOSE BLOOD LEVEL;
HEART INFARCTION;
HUMAN;
HYPERTENSION;
HYPOGLYCEMIA;
LACTIC ACIDOSIS;
LIVER INJURY;
NON INSULIN DEPENDENT DIABETES MELLITUS;
PRIORITY JOURNAL;
REVIEW;
SYNDROME;
ANTIHYPERTENSIVE AGENTS;
ANTILIPEMIC AGENTS;
DIABETES MELLITUS, TYPE 2;
HUMANS;
HYPERLIPIDEMIAS;
HYPERTENSION;
HYPOGLYCEMIC AGENTS;
RISK FACTORS;
SYNDROME;
|
|
EID: 0034066672
PISSN: 15209156
EISSN: None
Source Type: Journal
DOI: 10.1089/152091599316801 Document Type: Review |
|
Times cited : (15)
|
|
References (57)
|
